R3 Vascular

Mountain View, CA · Founded 2019 · Privately Held (backing)

Developer of medical metallic stents devices designed to treat peripheral arterial diseases. R3 Vascular is based in Mountain View, CA and was founded in 2019. Its last known valuation is $145 million. It has raised $106 million across 2 recorded rounds; the latest was a $72.5 million later-stage round in Apr 2024.

Last price · $/share
—
Implied valuation
$145.0M
Total raised
$105.6M
Last round
Later Stage VC
Apr 2024

Who backs R3 Vascular?

6 investors
InvestorType
Deerfield ManagementVenture capital
415 Capital—
M&L Group—
MedFocus—
Philips Ventures—
Wexford Capital—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

R3 Vascular investors

6 investors are on record for R3 Vascular, including Deerfield Management, 415 Capital, M&L Group and MedFocus. The later-stage round in Apr 2024 drew 34 investors.

Free account
More of R3 Vascular with a free account
  • ·Watch R3 Vascular: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 6 firms already write checks for companies like R3 Vascular. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View